Gene: PARP12
Official Full Name: poly(ADP-ribose) polymerase family member 12provided by HGNC
Gene Summary: Enables NAD+-protein ADP-ribosyltransferase activity. Involved in protein auto-ADP-ribosylation. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15344 | PARP12 Knockout cell line (HeLa) | Human | PARP12 | 1:3~1:6 | Negative | Online Inquiry |
KO15345 | PARP12 Knockout cell line (HCT 116) | Human | PARP12 | 1:2~1:4 | Negative | Online Inquiry |
KO15346 | PARP12 Knockout cell line (HEK293) | Human | PARP12 | 1:3~1:6 | Negative | Online Inquiry |
KO15347 | PARP12 Knockout cell line (A549) | Human | PARP12 | 1:3~1:4 | Negative | Online Inquiry |
PARP12 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to facilitate the study of poly(ADP-ribose) polymerase 12 (PARP12) function and its implications in various biological processes. These cell lines are generated through advanced CRISPR-Cas9 gene-editing technology, effectively disrupting the PARP12 gene, thereby enabling researchers to investigate the role of PARP12 in nucleic acid metabolism, stress responses, and cellular signaling pathways.
The key functionality of PARP12 Gene Knockout Cell Lines lies in their ability to provide insights into the mechanisms through which PARP12 influences cellular responses to DNA damage and regulates immunological responses. With PARP12 being implicated in the modulation of interferon responses and its role in viral infections, these knockout models offer significant avenues for studying host-pathogen interactions and the molecular underpinnings of immune regulation.
The scientific importance of these cell lines extends into both research and clinical settings. By enabling the examination of PARP12's contributions to oncogenesis, inflammation, and cellular resilience, researchers can uncover novel therapeutic targets for various diseases, including cancer and autoimmune disorders. Additionally, these cell lines serve as robust tools for drug discovery, allowing for the evaluation of therapeutic agents that modulate PARP12 activity.
Compared to traditional cell models, PARP12 Gene Knockout Cell Lines provide unique advantages such as specificity in genetic alteration and the elimination of confounding factors associated with endogenous PARP12 expression. This precise knockout renders high reproducibility and reliability in experimental outcomes, enhancing the interpretation of data.
For researchers and clinicians alike, the value of PARP12 Gene Knockout Cell Lines is underscored by their potential to lead to groundbreaking discoveries in therapeutic strategies. By elucidating the function of PARP12 in cellular mechanisms, these models represent a pivotal resource in advancing scientific exploration and developing innovative treatments.
Our company prides itself on delivering high-quality biological products backed by extensive research and expertise in genetic engineering. We are committed to empowering the scientific community with cutting-edge tools that advance life sciences research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.